Corbus Pharmaceuticals Holdings, Inc. — Director's Dealing 2018

Jan 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CIK: 0001595097
Period of Report: 2018-01-04

Reporting Person: Moran Sean F. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-01-04	Stock Option(right to buy)	$8.35	A	175000	Acquired	2028-01-04	Common Stock (175000)	Direct

Footnotes

F1: The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on January 4, 2019, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 4, 2019.